It's a positive step that Pfizer are still continung to evaluate the candidates & a milestone has been triggered, I'd go out an a limb & say another $500K payment. I guess we will be able to see come the quarterly report end of July.
Big news will be when/if Pfizer take out a commercial license on a candidate with a milestone then triggered in the $2M range thats when a licensing agreement will be formalised & we can start looking at toxicity & proof of concept studies triggering further milestones before eventually moving into the clinic with Phase I studies - it's a long road ahead but we are ticking boxes.
PYC Price at posting:
4.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)